Respiratory Care Devices Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)
This Report Provides In-Depth Analysis of the Respiratory Care Devices Market Report Prepared by P&S Intelligence, Segmented by Type (Therapeutic, Monitoring, Diagnostic), Indication (COPD, Sleep Apnea, Asthma, Infectious Diseases), End User (Hospitals, Homecare Settings, Emergency Centers), and Geographical Outlook for the Period of 2019 to 2032
- Published: February 2025
- Pages: 290
- Report Code: 10222
Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by type
1.4.2. Market size breakdown, by application
1.4.3. Market size breakdown, by end user
1.4.4. Market size breakdown, by region
1.4.5. Market size breakdown, by country
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
5.1. Market Dynamics
5.1.1. Trends
5.1.2. Drivers
5.1.3. Restraints/challenges
5.1.4. Impact analysis of drivers/restraints
5.2. Impact of COVID-19
5.3. Porter’s Five Forces Analysis
5.3.1. Bargaining power of buyers
5.3.2. Bargaining power of suppliers
5.3.3. Threat of new entrants
5.3.4. Intensity of rivalry
5.3.5. Threat of substitutes
5.4. Growth Opportunities in Global Respiratory Care Devices Market
5.5. Pricing Analysis
5.6. Technology Analysis
5.7. Go-To Market Strategy
Chapter 6. Competitive Landscape
6.1. List of Market Players and their Offerings
6.2. Market Share of Key Players (2023)
6.3. Competitive Benchmarking of Key Players
6.4. Product Benchmarking of Key Players
6.5. Recent Strategic Developments
Chapter 7. Global Market
7.1. Overview
7.2. Market Revenue, by Type (2019–2030)
7.3. Market Revenue, by Application (2019–2030)
7.3.1. Therapeutic market revenue, by type (2019–2030)
7.3.2. Monitoring market revenue, by type (2019–2030)
7.3.3. Diagnostic market revenue, by type (2019–2030)
7.4. Market Revenue, by End User (2019–2030)
7.5. Market Revenue, by Region (2019–2030)
Chapter 8. North America Market
8.1. Overview
8.2. Market Revenue, by Type (2019–2030)
8.3. Market Revenue, by Application (2019–2030)
8.3.1. Therapeutic market revenue, by type (2019–2030)
8.3.2. Monitoring market revenue, by type (2019–2030)
8.3.3. Diagnostic market revenue, by type (2019–2030)
8.4. Market Revenue, by End User (2019–2030)
8.5. Market Revenue, by Country (2019–2030)
Chapter 9. Europe Market
9.1. Overview
9.2. Market Revenue, by Type (2019–2030)
9.3. Market Revenue, by Application (2019–2030)
9.3.1. Therapeutic market revenue, by type (2019–2030)
9.3.2. Monitoring market revenue, by type (2019–2030)
9.3.3. Diagnostic market revenue, by type (2019–2030)
9.4. Market Revenue, by End User (2019–2030)
9.5. Market Revenue, by Country (2019–2030)
Chapter 10. APAC Market
10.1. Overview
10.2. Market Revenue, by Type (2019–2030)
10.3. Market Revenue, by Application (2019–2030)
10.3.1. Therapeutic market revenue, by type (2019–2030)
10.3.2. Monitoring market revenue, by type (2019–2030)
10.3.3. Diagnostic market revenue, by type (2019–2030)
10.4. Market Revenue, by End User (2019–2030)
10.5. Market Revenue, by Country (2019–2030)
Chapter 11. LATAM Market
11.1. Overview
11.2. Market Revenue, by Type (2019–2030)
11.3. Market Revenue, by Application (2019–2030)
11.3.1. Therapeutic market revenue, by type (2019–2030)
11.3.2. Monitoring market revenue, by type (2019–2030)
11.3.3. Diagnostic market revenue, by type (2019–2030)
11.4. Market Revenue, by End User (2019–2030)
11.5. Market Revenue, by Country (2019–2030)
Chapter 12. MEA Market
12.1. Overview
12.2. Market Revenue, by Type (2019–2030)
12.3. Market Revenue, by Application (2019–2030)
12.3.1. Therapeutic market revenue, by type (2019–2030)
12.3.2. Monitoring market revenue, by type (2019–2030)
12.3.3. Diagnostic market revenue, by type (2019–2030)
12.4. Market Revenue, by End User (2019–2030)
12.5. Market Revenue, by Country (2019–2030)
Chapter 13. U.S. Market
13.1. Overview
13.2. Market Revenue, by Type (2019–2030)
13.3. Market Revenue, by Application (2019–2030)
13.3.1. Therapeutic market revenue, by type (2019–2030)
13.3.2. Monitoring market revenue, by type (2019–2030)
13.3.3. Diagnostic market revenue, by type (2019–2030)
13.4. Market Revenue, by End User (2019–2030)
13.5. Market Revenue, by Application (2019–2030)
Chapter 14. Canada Market
14.1. Overview
14.2. Market Revenue, by Type (2019–2030)
14.3. Market Revenue, by Application (2019–2030)
14.3.1. Therapeutic market revenue, by type (2019–2030)
14.3.2. Monitoring market revenue, by type (2019–2030)
14.3.3. Diagnostic market revenue, by type (2019–2030)
14.4. Market Revenue, by End User (2019–2030)
Chapter 15. Germany Market
15.1. Overview
15.2. Market Revenue, by Type (2019–2030)
15.3. Market Revenue, by Application (2019–2030)
15.3.1. Therapeutic market revenue, by type (2019–2030)
15.3.2. Monitoring market revenue, by type (2019–2030)
15.3.3. Diagnostic market revenue, by type (2019–2030)
15.4. Market Revenue, by End User (2019–2030)
Chapter 16. France Market
16.1. Overview
16.2. Market Revenue, by Type (2019–2030)
16.3. Market Revenue, by Application (2019–2030)
16.3.1. Therapeutic market revenue, by type (2019–2030)
16.3.2. Monitoring market revenue, by type (2019–2030)
16.3.3. Diagnostic market revenue, by type (2019–2030)
16.4. Market Revenue, by End User (2019–2030)
Chapter 17. U.K. Market
17.1. Overview
17.2. Market Revenue, by Type (2019–2030)
17.3. Market Revenue, by Application (2019–2030)
17.3.1. Therapeutic market revenue, by type (2019–2030)
17.3.2. Monitoring market revenue, by type (2019–2030)
17.3.3. Diagnostic market revenue, by type (2019–2030)
17.4. Market Revenue, by End User (2019–2030)
Chapter 18. Italy Market
18.1. Overview
18.2. Market Revenue, by Type (2019–2030)
18.3. Market Revenue, by Application (2019–2030)
18.3.1. Therapeutic market revenue, by type (2019–2030)
18.3.2. Monitoring market revenue, by type (2019–2030)
18.3.3. Diagnostic market revenue, by type (2019–2030)
18.4. Market Revenue, by End User (2019–2030)
Chapter 19. Spain Market
19.1. Overview
19.2. Market Revenue, by Type (2019–2030)
19.3. Market Revenue, by Application (2019–2030)
19.3.1. Therapeutic market revenue, by type (2019–2030)
19.3.2. Monitoring market revenue, by type (2019–2030)
19.3.3. Diagnostic market revenue, by type (2019–2030)
19.4. Market Revenue, by End User (2019–2030)
Chapter 20. Japan Market
20.1. Overview
20.2. Market Revenue, by Type (2019–2030)
20.3. Market Revenue, by Application (2019–2030)
20.3.1. Therapeutic market revenue, by type (2019–2030)
20.3.2. Monitoring market revenue, by type (2019–2030)
20.3.3. Diagnostic market revenue, by type (2019–2030)
20.4. Market Revenue, by End User (2019–2030)
Chapter 21. China Market
21.1. Overview
21.2. Market Revenue, by Type (2019–2030)
21.3. Market Revenue, by Application (2019–2030)
21.3.1. Therapeutic market revenue, by type (2019–2030)
21.3.2. Monitoring market revenue, by type (2019–2030)
21.3.3. Diagnostic market revenue, by type (2019–2030)
21.4. Market Revenue, by End User (2019–2030)
Chapter 22. India Market
22.1. Overview
22.2. Market Revenue, by Type (2019–2030)
22.3. Market Revenue, by Application (2019–2030)
22.3.1. Therapeutic market revenue, by type (2019–2030)
22.3.2. Monitoring market revenue, by type (2019–2030)
22.3.3. Diagnostic market revenue, by type (2019–2030)
22.4. Market Revenue, by End User (2019–2030)
Chapter 23. Australia Market
23.1. Overview
23.2. Market Revenue, by Type (2019–2030)
23.3. Market Revenue, by Application (2019–2030)
23.3.1. Therapeutic market revenue, by type (2019–2030)
23.3.2. Monitoring market revenue, by type (2019–2030)
23.3.3. Diagnostic market revenue, by type (2019–2030)
23.4. Market Revenue, by End User (2019–2030)
Chapter 24. South Korea Market
24.1. Overview
24.2. Market Revenue, by Type (2019–2030)
24.3. Market Revenue, by Application (2019–2030)
24.3.1. Therapeutic market revenue, by type (2019–2030)
24.3.2. Monitoring market revenue, by type (2019–2030)
24.3.3. Diagnostic market revenue, by type (2019–2030)
24.4. Market Revenue, by End User (2019–2030)
Chapter 25. Brazil Market
25.1. Overview
25.2. Market Revenue, by Type (2019–2030)
25.3. Market Revenue, by Application (2019–2030)
25.3.1. Therapeutic market revenue, by type (2019–2030)
25.3.2. Monitoring market revenue, by type (2019–2030)
25.3.3. Diagnostic market revenue, by type (2019–2030)
25.4. Market Revenue, by End User (2019–2030)
Chapter 26. Mexico Market
26.1. Overview
26.2. Market Revenue, by Type (2019–2030)
26.3. Market Revenue, by Application (2019–2030)
26.3.1. Therapeutic market revenue, by type (2019–2030)
26.3.2. Monitoring market revenue, by type (2019–2030)
26.3.3. Diagnostic market revenue, by type (2019–2030)
26.4. Market Revenue, by End User (2019–2030)
Chapter 27. Saudi Arabia Market
27.1. Overview
27.2. Market Revenue, by Type (2019–2030)
27.3. Market Revenue, by Application (2019–2030)
27.3.1. Therapeutic market revenue, by type (2019–2030)
27.3.2. Monitoring market revenue, by type (2019–2030)
27.3.3. Diagnostic market revenue, by type (2019–2030)
27.4. Market Revenue, by End User (2019–2030)
Chapter 28. South Africa Market
28.1. Overview
28.2. Market Revenue, by Type (2019–2030)
28.3. Market Revenue, by Application (2019–2030)
28.3.1. Therapeutic market revenue, by type (2019–2030)
28.3.2. Monitoring market revenue, by type (2019–2030)
28.3.3. Diagnostic market revenue, by type (2019–2030)
28.4. Market Revenue, by End User (2019–2030)
Chapter 29. U.A.E. Market
29.1. Overview
29.2. Market Revenue, by Type (2019–2030)
29.3. Market Revenue, by Application (2019–2030)
29.3.1. Therapeutic market revenue, by type (2019–2030)
29.3.2. Monitoring market revenue, by type (2019–2030)
29.3.3. Diagnostic market revenue, by type (2019–2030)
29.4. Market Revenue, by End User (2019–2030)
Chapter 30. Company Profiles
30.1. Medtronic
30.1.1. Business overview
30.1.2. Product and service offerings
30.1.3. Key financial summary
30.2. ResMed
30.2.1. Business overview
30.2.2. Product and service offerings
30.2.3. Key financial summary
30.3. Fisher & Paykel Healthcare Limited
30.3.1. Business overview
30.3.2. Product and service offerings
30.3.3. Key financial summary
30.4. Teleflex Incorporated
30.4.1. Business overview
30.4.2. Product and service offerings
30.4.3. Key financial summary
30.5. Hamilton Medical AG
30.5.1. Business overview
30.5.2. Product and service offerings
30.5.3. Key financial summary
30.6. Drägerwerk AG & Co. KGaA
30.6.1. Business overview
30.6.2. Product and service offerings
30.6.3. Key financial summary
30.7. Getinge
30.7.1. Business overview
30.7.2. Product and service offerings
30.7.3. Key financial summary
30.8. NIHON KOHDEN CORPORATION
30.8.1. Business overview
30.8.2. Product and service offerings
30.8.3. Key financial summary
Chapter 31. Appendix
31.1. Abbreviations
31.2. Sources and References
31.3. Related Reports
